Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Could a more personal approach improve flu season outreach?
Preliminary findings from a flu outreach pilot suggest that personalized engagement may help increase participation in preventive care.
As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.
Losing a pregnancy can have traumatic psychological impacts on women. When left untreated, they can have detrimental and long-lasting effects on the health and well-being of these women and their families.
As a key resource during the COVID-19 pandemic, pharmacists have quickly been acknowledged as crucial contributors to patient care and better health outcomes.
We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.
More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex challenge.
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-related health challenges within their member population.
